Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
Cooper Companies: Firm's proposed $1.2 bil. acquisition of Ocular Sciences garners required shareholder approval Nov. 16. However, closure of the transaction, originally expected by November, continues to be delayed as the Federal Trade Commission reviews additional information it requested in September to supplement the two companies' initial Aug. 6 submission of merger-related information (1"The Gray Sheet" Sept. 13, 2004, p. 24). Cooper now predicts the transaction will close during the first half of its fiscal 2005, which began Nov. 1...
You may also be interested in...
AngioDynamics Aims To Leverage Endovenous Laser Reimbursement
AngioDynamics is developing "more aggressive" marketing efforts for its VenaCure laser ablation system on the heels of favorable Medicare reimbursement codes and rates for 2005
AngioDynamics Aims To Leverage Endovenous Laser Reimbursement
AngioDynamics is developing "more aggressive" marketing efforts for its VenaCure laser ablation system on the heels of favorable Medicare reimbursement codes and rates for 2005
Cooper/Ocular Sciences Merger Could Be Delayed By FTC Info Request
Cooper Companies' near-term sales projections could be impacted by personnel retention issues if a recent FTC information request delays the firm's pending acquisition of Ocular Sciences